Press Releases

Press Releases

Date Title  
01/10/14
Summary ToggleAkebia Therapeutics Strengthens Its Leadership Team with Key Additions
 
10/16/13
Summary ToggleAkebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
 
08/28/13
Summary ToggleAkebia Appoints Renal Industry Veteran John P. Butler as President and CEO
 
07/24/13
Summary ToggleAkebia Therapeutics Announces Initiation of Phase 2b Trial of Oral Anemia Candidate
 
06/04/13
Summary ToggleAkebia Closes $41 Million Series C
 
04/05/12
Summary ToggleAkebia Meets Primary Endpoint in Phase 2 Study of Once-Daily, Oral Anemia Treatment, AKB-6548
 
01/09/12
Summary ToggleAkebia Draws Down $4.1 Million Series B Financing Tranche
 
11/21/11
Summary ToggleAkebia Initiates Phase 1 Study of First-In-Class HPTPβ Inhibitor for Diabetic Macular Edema
 
11/15/11
Summary ToggleAkebia Therapeutics Announces Presentation of Clinical Data at Kidney Week 2011
 
06/23/11
Summary ToggleAkebia Announces Initiation of Phase 2a Dose Range Finding Study of AKB-6548 for Anemia
 
Displaying 121 - 130 of 142 results
 
Print Page
Print Page
Email Page
Email Page
Contact IR
Contact IR
Email Alerts
Email Alerts
Tear Sheet
Tear Sheet